In the immediate aftermath of the Obamacare rollout, pharma and healthcare M&A fell. Now, however, it's back up, on deals like Monday morning's Covidien - Medtronic announcement, a merger valued at $43 billion. While some deals in the healthcare industry are being guided by synergies, other, like Monday's MergerTalk deal, are being guided by strategy. Medtronic needs to relocate its Minnesota tax base to Ireland, where Covidien is based, in order to save on a hefty U.S. tax bill. Medtronic isn't the only one: Pfizer attempted to acquire AstraZeneca, for the same reasons. The Deal's Jon Marino and Sarah Pringle have details from Wall Street.

More from Video

Video: Here Is Why Carvana Isn't Worried About Amazon

Video: Here Is Why Carvana Isn't Worried About Amazon

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

This Could Be the Summer of Hard Seltzer

This Could Be the Summer of Hard Seltzer